David Heikkinen is Chief Executive Officer of both Heikkinen Energy Advisors and its wholly owned broker/dealer, Heikkinen Energy Securities LLC. Prior to founding the firm in December 2012, he was ...
Tom van Aken is Avantium’s CEO and a member of the Management Board. Mr. van Aken joined Avantium in 2002 as Vice President of Business Development. After becoming Vice President Global Marketing and ...
Jin Kang is the President, Chief Executive Officer, and a Director of WidePoint Corporation, appointed on July 5, 2017. Previously, Mr. Kang served as Executive Vice President and COO following ...
TWST: It has been a few years since you last spoke with us, so let’s start with a refresher on Shelter Rock Management, a bit about the company’s history and your ...
Silviu Itescu, MBBS, FRACP, is the Chief Executive Officer and Managing Director of Mesoblast Limited. Dr. Itescu has served on Mesoblast’s board of directors since the company’s founding in 2004, was ...
David Swartz is a senior equity analyst, consumer research, for Morningstar, Inc. He covers department stores, specialty retailers, and manufacturers and retailers of apparel, footwear, and ...
Marvin Fong, CFA, is a Director at BTIG with coverage of Consumer and Technology Services, including e-commerce platforms, information service providers, and automotive services. Previously, he ...
Charles “Chuck” Nabhan is a Managing Director and Research Analyst at Stephens Inc. covering the financial technology industry, including the payment, payroll, bank and restaurant/retail technology ...
TWST: We’ve spoken before, but can you give our readers a brief overview of the company and how it’s evolved over the years? And also tell us how sustainability ...
Catriona Duncan, CFA, is a Co-Founder and Portfolio Manager of Sankota Capital LLC, an investment firm focused on active management of small- and mid-cap equities. Previously, she was a Research ...
Gus A. Galá is a Senior Equity Research Analyst covering Fintech and Info Services at Monness, Crespi, Hardt & Co., an independent research, sales and trading firm. Prior to joining MCH in 2023, Mr.
Jon Pilcher is Chief Executive Officer/Managing Director of Neuren Pharmaceuticals Ltd. Mr. Pilcher joined Neuren in August 2013 as CFO and was appointed CEO in May 2020. He has played a central role ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results